Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06222671 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Name: A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) — clinical trial record (NCT06222671)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2024-03-22

View on ClinicalTrials.gov ↗

Record status

This record was last updated March 11, 2025 (before its estimated September 22, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2025-03-06

Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Primary completion date2025-11-30→2025-09-22

Start dateestimated 2024-01-31→confirmed 2024-03-22

Study sitesdetails revised at 6 of 6 sites

2024-01-24

Original filing

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

Ankylosing Spondylitis

176 trials monitored

See 6 trials at risk

This study will evaluate the effect and safety of 608 in patients with nr-axSpA.

Trial Details

NCT Number	NCT06222671
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Axial Spondyloarthritis
Enrollment	180 participants
Start Date	2024-03-22
Primary Completion	2025-09-22 (estimated)
Study Completion	2025-11-30 (estimated)
Updated on ClinicalTrials.gov	2025-03-11